Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 2048904

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 2048904

Neurothrombectomy Devices Market Size, Share, and Growth Analysis, By Device Type, By Technique, By Age Group, By Procedure Type, By Application, By End User, By Region - Industry Forecast 2026-2033

PUBLISHED:
PAGES: 157 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Neurothrombectomy Devices Market size was valued at USD 824.4 Million in 2024 and is poised to grow from USD 880.46 Million in 2025 to USD 1490.32 Million by 2033, growing at a CAGR of 6.8% during the forecast period (2026-2033).

The global market for neurothrombectomy devices is significantly influenced by an aging population and the increasing prevalence of ischemic strokes, which leads to a focus on mechanical clot retrieval as the standard treatment. This market includes innovative solutions such as programmable stent retrievers and aspiration catheters designed to effectively eliminate cerebral thrombi and restore blood flow, crucial for reducing disability and healthcare costs. Advances in clinical evidence and an expansion of treatment timeframes are propelling market growth, widening patient eligibility and encouraging investment. As more stroke centers establish neurointerventional suites and enhance multidisciplinary training, the demand for diverse device options rises, fostering regional collaboration, improving patient outcomes, and allowing manufacturers to scale operations, lower costs, and penetrate new markets.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neurothrombectomy Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Neurothrombectomy Devices Market Segments Analysis

Global neurothrombectomy devices market is segmented by device type, technique, age group, procedure type, application, end user and region. Based on device type, the market is segmented into Stent Retrievers, Aspiration / Suction Devices, Clot Retrieval Devices, Balloon Guide Catheters and Support Catheters & Microcatheters. Based on technique, the market is segmented into Aspiration Thrombectomy, Mechanical Thrombectomy and Combined Technique. Based on age group, the market is segmented into Adult and Geriatric. Based on procedure type, the market is segmented into Minimally Invasive Procedures and Catheter-Based Neurovascular Procedures. Based on application, the market is segmented into Acute Ischemic Stroke, Hemorrhagic Stroke and Neurovascular Occlusions. Based on end user, the market is segmented into Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Neurology Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Neurothrombectomy Devices Market

The advancement of high-quality imaging systems has significantly enhanced clinicians' ability to identify blockages and effectively deploy neurothrombectomy devices in real-time, leading to improved procedural outcomes. This elevated imaging quality has mitigated uncertainties associated with procedures, fostering greater confidence among hospitals in utilizing neurothrombectomy techniques. Additionally, enhanced imaging has paved the way for developing innovative devices and procedures, along with specialized training for medical professionals in delivering neurothrombectomy services. This amalgamation of factors has not only improved the overall appeal of these services offered by hospitals but has also contributed to the widespread acceptance and growth of the global neurothrombectomy devices market.

Restraints in the Global Neurothrombectomy Devices Market

The intricate nature of neurothrombectomy procedures, combined with the specialized skills required of neurointerventionalists, poses significant challenges for market expansion. This complexity limits the number of healthcare centers capable of providing such services. Moreover, the lengthy learning curve and the necessity for well-coordinated stroke systems and trained personnel compel hospitals to invest substantial resources and commitment to develop appropriate programs for these procedures. In addition, the absence of specialized expertise and structured training programs can lead to slow adoption rates and disrupted referral patterns, ultimately resulting in unmet demand for these devices in numerous regions, despite their clinical necessity.

Market Trends of the Global Neurothrombectomy Devices Market

The Global Neurothrombectomy Devices market is witnessing a significant trend driven by the integration of AI technologies into imaging and procedural planning. This advancement enables personalized device selection and provides real-time guidance to clinicians, allowing for tailored neurothrombectomy approaches based on individual patient anatomy and clot characteristics. Algorithm-based navigation and workflow orchestration enhance clinical decision-making while minimizing procedural variability, benefiting even less experienced operators. Such innovations foster closer collaborations between device manufacturers and healthcare systems, refining tool designs and training pathways. Consequently, this continuous cycle of iterative improvements enhances product adoption rates and elevates patient care standards across diverse hospital settings.

Product Code: SQMIG35A3458

Table of Contents

Introduction

  • Objectives of the Study
  • Market Definition & Scope

Research Methodology

  • Research Process
  • Secondary & Primary Data Methods
  • Market Size Estimation Methods

Executive Summary

  • Global Market Outlook
  • Key Market Highlights
  • Segmental Overview
  • Competition Overview

Market Dynamics & Outlook

  • Macro-Economic Indicators
  • Drivers & Opportunities
  • Restraints & Challenges
  • Supply Side Trends
  • Demand Side Trends
  • Porters Analysis & Impact
    • Competitive Rivalry
    • Threat of Substitute
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factors
  • Market Impacting Factors
  • Top Investment Pockets
  • Ecosystem Mapping
  • Market Attractiveness Index 2025
  • PESTEL Analysis
  • Regulatory Landscape
  • Value Chain Analysis
  • Case Studies
  • Technology Assessment
  • Customer & Buying Criteria Analysis
  • Pipeline Analysis
  • Disease Epidemiology

Global Neurothrombectomy Devices Market Size by Device Type & CAGR (2026-2033)

  • Market Overview
  • Stent Retrievers
  • Aspiration / Suction Devices
  • Clot Retrieval Devices
  • Balloon Guide Catheters
  • Support Catheters & Microcatheters

Global Neurothrombectomy Devices Market Size by Technique & CAGR (2026-2033)

  • Market Overview
  • Aspiration Thrombectomy
  • Mechanical Thrombectomy
  • Combined Technique

Global Neurothrombectomy Devices Market Size by Age Group & CAGR (2026-2033)

  • Market Overview
  • Adult
  • Geriatric

Global Neurothrombectomy Devices Market Size by Procedure Type & CAGR (2026-2033)

  • Market Overview
  • Minimally Invasive Procedures
  • Catheter-Based Neurovascular Procedures

Global Neurothrombectomy Devices Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Acute Ischemic Stroke
  • Hemorrhagic Stroke
  • Neurovascular Occlusions

Global Neurothrombectomy Devices Market Size by End User & CAGR (2026-2033)

  • Market Overview
  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Specialty Neurology Clinics
  • Others

Global Neurothrombectomy Devices Market Size & CAGR (2026-2033)

  • North America (Device Type, Technique, Age Group, Procedure Type, Application, End User)
    • US
    • Canada
  • Europe (Device Type, Technique, Age Group, Procedure Type, Application, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Device Type, Technique, Age Group, Procedure Type, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Device Type, Technique, Age Group, Procedure Type, Application, End User)
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Device Type, Technique, Age Group, Procedure Type, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Medtronic plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stryker Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Penumbra, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MicroPort Scientific Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Integer Holdings Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merit Medical Systems, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Rapid Medical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Acandis GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Asahi Intecc Co., Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Phenox GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Balt Group
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cerus Endovascular
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Perflow Medical Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cook Medical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kaneka Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!